These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30051297)

  • 21. Exacerbation of seborrheic dermatitis by topical fluorouracil.
    Brodell EE; Smith E; Brodell RT
    Arch Dermatol; 2011 Feb; 147(2):245-6. PubMed ID: 21339458
    [No Abstract]   [Full Text] [Related]  

  • 22. The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer.
    Kennedy C; Bajdik CD; Willemze R; De Gruijl FR; Bouwes Bavinck JN;
    J Invest Dermatol; 2003 Jun; 120(6):1087-93. PubMed ID: 12787139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy, Safety, and Tolerability of 4% 5-Fluorouracil Cream in a Novel Patented Aqueous Cream Containing Peanut Oil Once Daily Compared With 5% 5-Fluorouracil Cream Twice Daily: Meeting the Challenge in the Treatment of Actinic Keratosis.
    Dohil MA
    J Drugs Dermatol; 2016 Oct; 15(10):1218-1224. PubMed ID: 27741339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dasatinib-induced Seborrheic Dermatitis-like Eruption.
    Riahi RR; Cohen PR
    J Clin Aesthet Dermatol; 2017 Jul; 10(7):23-27. PubMed ID: 29104720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topical fluorouracil therapy for precancers and cancers of the skin.
    Cullen SI
    J Am Geriatr Soc; 1979 Dec; 27(12):529-35. PubMed ID: 159921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ectropion following topical 5-fluorouracil treatment.
    Villamaria E; Dacy N; Preston A; Housewright C
    Proc (Bayl Univ Med Cent); 2023; 36(2):249-250. PubMed ID: 36876262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Destructive procedures are the standard of care for treatment of actinic keratoses.
    Feldman SR; Fleischer AB; Williford PM; Jorizzo JL
    J Am Acad Dermatol; 1999 Jan; 40(1):43-7. PubMed ID: 9922011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of topical treatments for seborrheic keratoses: a systematic review.
    Natarelli N; Krenitsky A; Hennessy K; Moore S; Grichnik J
    J Dermatolog Treat; 2023 Dec; 34(1):2133532. PubMed ID: 36215682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transient eruptive seborrheic keratoses associated with erythrodermic psoriasis and erythrodermic drug eruption: report of two cases.
    Flugman SL; McClain SA; Clark RA
    J Am Acad Dermatol; 2001 Dec; 45(6 Suppl):S212-4. PubMed ID: 11712062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial.
    Jorizzo J; Weiss J; Furst K; VandePol C; Levy SF
    Arch Dermatol; 2004 Jul; 140(7):813-6. PubMed ID: 15262691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Actinic keratoses treated with a combination of topical 5-fluorouracil and dinitrochlorobenzene.
    Price NM
    Dermatologica; 1979; 158(4):279-86. PubMed ID: 428615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pharmacokinetic evaluation of 0.5% and 5% fluorouracil topical cream in patients with actinic keratosis.
    Levy S; Furst K; Chern W
    Clin Ther; 2001 Jun; 23(6):908-20. PubMed ID: 11440290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The expression of p63 in actinic keratoses, seborrheic keratosis, and cutaneous squamous cell carcinomas.
    Wrone DA; Yoo S; Chipps LK; Moy RL
    Dermatol Surg; 2004 Oct; 30(10):1299-302. PubMed ID: 15458526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical diclofenac: new preparation. Moderate efficacy in actinic keratosis.
    Prescrire Int; 2004 Aug; 13(72):138-9. PubMed ID: 15532138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel cosmetic antifungal/anti-inflammatory topical gel for the treatment of mild to moderate seborrheic dermatitis of the face: an open-label trial utilizing clinical evaluation and erythema-directed digital photography.
    Dall' Oglio F; Tedeschi A; Fusto CM; Lacarrubba F; Dinotta F; Micali G
    G Ital Dermatol Venereol; 2017 Oct; 152(5):436-440. PubMed ID: 28121079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The treatment of inflammatory facial dermatoses with topical corticosteroids: focus on clocortolone pivalate 0.1% cream.
    Kircik LH; Del Rosso JQ
    J Drugs Dermatol; 2012 Oct; 11(10):1194-8. PubMed ID: 23134984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seborrheic dermatitis-like eruption in patients taking isotretinoin therapy for acne: retrospective study of five patients.
    Barzilai A; David M; Trau H; Hodak E
    Am J Clin Dermatol; 2008; 9(4):255-61. PubMed ID: 18572976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses.
    Lawrence N; Cox SE; Cockerell CJ; Freeman RG; Cruz PD
    Arch Dermatol; 1995 Feb; 131(2):176-81. PubMed ID: 7857114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rational management of papulopustular rosacea with concomitant facial seborrheic dermatitis: a case report.
    McFalda WL; Roebuck HL
    J Clin Aesthet Dermatol; 2011 Jan; 4(1):40-2. PubMed ID: 21278898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seborrheic keratoses: appearance in course of exfoliative erythroderma and regression associated with histologic mononuclear cell inflammation.
    Berman A; Winkelmann RK
    Arch Dermatol; 1982 Aug; 118(8):615-8. PubMed ID: 6213206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.